本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Recursion Pharmaceuticals, Inc.

3.54
+0.350010.97%
盤後3.550.0080+0.23%18:17 EDT
成交量:2,819.26萬
成交額:9,834.25萬
市值:18.94億
市盈率:-3.46
高:3.59
開:3.28
低:3.26
收:3.19
52周最高:7.18
52周最低:2.77
股本:5.35億
流通股本:5.22億
量比:2.26
換手率:5.40%
股息:- -
股息率:- -
每股收益(TTM):-1.0219
每股收益(LYR):-1.4410
淨資產收益率:-56.58%
總資產收益率:-27.33%
市淨率:2.07
市盈率(LYR):-2.46

資料載入中...

2023/06/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/20

重要事件披露

Form 8-K - Current report
2023/06/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/13

重要事件披露

Form 8-K - Current report
2023/06/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/09

重要事件披露

Form 8-K - Current report
2023/06/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/30

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/26

重要事件披露

Form 8-K - Current report
2023/05/23

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/18

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/17

重要事件披露

Form 8-K - Current report
2023/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities